Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids
George Loeffler, Eileen Delaney, Michael Hann
Brain Research Bulletin (2016) Vol. 126, pp. 8-28
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective
Koby Cohen, Aviv Weinstein
Frontiers in Public Health (2018) Vol. 6
Open Access | Times Cited: 153
Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review
Claire M. Gorey, Lauren Kuhns, Eleni Smaragdi, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 1, pp. 37-58
Open Access | Times Cited: 98
Cannabinoid exposure during pregnancy and its impact on immune function
Catherine Dong, Jingwen Chen, Amy Harrington, et al.
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 4, pp. 729-743
Open Access | Times Cited: 71
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
Noreen Dadirai Mdege, Nick Meader, Charlie Lloyd, et al.
Public Health Research (2017) Vol. 5, Iss. 4, pp. 1-138
Open Access | Times Cited: 65
Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature
Patil Armenian, Michael A. Darracq, Jirair Gevorkyan, et al.
Neuropharmacology (2017) Vol. 134, pp. 82-91
Closed Access | Times Cited: 55
Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiency
Florian Franz, Verena Angerer, Hanna Jechle, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2017) Vol. 55, Iss. 9
Closed Access | Times Cited: 52
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan, Oliver G. Bosch, Darshan Singh, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 52
Children Intoxicated with Psychoactive Substances: The Health Status on Admission to Hospital Based on Medical Records
Dorota Kosiorek, Jolanta Lewko, Ewa Romankiewicz
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1771-1771
Open Access | Times Cited: 4
Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use
Anthea B. Mahesan Paul, Lary Simms, Saeideh Amini, et al.
Journal of Forensic Sciences (2017) Vol. 63, Iss. 4, pp. 1321-1324
Closed Access | Times Cited: 42
Adding more “spice” to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists
Ryan M. Alam, J. J. Keating
Drug Testing and Analysis (2019) Vol. 12, Iss. 3, pp. 297-315
Closed Access | Times Cited: 32
Inconsistencies in the assumptions linking punitive sanctions and use of cannabis and new psychoactive substances in Europe
Brendan Hughes, João Matias, Paul Griffiths
Addiction (2018) Vol. 113, Iss. 12, pp. 2155-2157
Open Access | Times Cited: 31
Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review
Melissa Hobbs, Nicola J. Kalk, Paul D. Morrison, et al.
European Neuropsychopharmacology (2018) Vol. 28, Iss. 12, pp. 1289-1304
Open Access | Times Cited: 27
A Functional Platform for the Detection of JWH‐073 as a Model for Synthetic Cannabinoids
Tulay Yilmaz Sengel, Emine Guler, Cansu Aydoğan, et al.
ChemElectroChem (2018) Vol. 5, Iss. 9, pp. 1253-1258
Closed Access | Times Cited: 24
Behavioral Effects of Developmental Exposure to JWH-018 in Wild-Type and Disrupted in Schizophrenia 1 (disc1) Mutant Zebrafish
Judit García‐González, Bruno de Quadros, William Havelange, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 319-319
Open Access | Times Cited: 18
Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019
Tracy Klein, Julia A. Dilley, Janessa M. Graves, et al.
Clinical Toxicology (2022) Vol. 60, Iss. 9, pp. 1024-1028
Closed Access | Times Cited: 10
Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists
Matilda Houston, Jody Morgan, Céline Kelso
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 92-109
Closed Access | Times Cited: 5
Epigenetic Effects of Drugs of Abuse
Thomas Heinbockel, Antonei B. Csòka
International Journal of Environmental Research and Public Health (2018) Vol. 15, Iss. 10, pp. 2098-2098
Open Access | Times Cited: 18
Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study
Stella Welter, Caroline Lücke, Alexandra P. Lam, et al.
European Addiction Research (2017) Vol. 23, Iss. 4, pp. 182-193
Open Access | Times Cited: 16
Evidence for public health on novel psychoactive substance use: a mixed-methods study
Kathryn Higgins, Nina O’Neill, Leeanne O’Hara, et al.
Public Health Research (2019) Vol. 7, Iss. 14, pp. 1-150
Open Access | Times Cited: 15
Uses, Effects and Toxicity of Synthetic Cannabinoids from the Perspective of People with Lived Experiences
Sulaf Assi, Danielle C. Marshall, Francesco Saverio Bersani, et al.
Journal of Psychoactive Drugs (2020) Vol. 52, Iss. 3, pp. 237-247
Open Access | Times Cited: 13
Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report
Franziska Gaunitz, Hilke Andresen‐Streichert
International Journal of Legal Medicine (2021) Vol. 136, Iss. 2, pp. 577-589
Open Access | Times Cited: 11
Determination of cross-reactivity of poly- and monoclonal antibodies for synthetic cannabinoids by direct SPR and ELISA
Nico Langer, Franziska Steinicke, Rainer Lindigkeit, et al.
Forensic Science International (2017) Vol. 280, pp. 25-34
Closed Access | Times Cited: 12
New Psychoactive Substances in Pediatric Patients
Brandon J. Warrick, Anita Paula Tataru, Roy Gerona
Pediatric Clinics of North America (2017) Vol. 64, Iss. 6, pp. 1223-1241
Closed Access | Times Cited: 11
The impact of legislation on acute synthetic cannabinoid harms resulting in ambulance attendance
Jasmin Grigg, Jessica J. Killian, Sharon Matthews, et al.
International Journal of Drug Policy (2020) Vol. 79, pp. 102720-102720
Closed Access | Times Cited: 10
Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users
Koby Cohen, Shiri Rosenzweig, Paola Rosca, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top